Clinical trial No longer in our active list Interventional Ages 21 and up

Endovascular repair for ascending aortic pathologies

Official title: Proposed Single Center Investigational Device Exemption: Feasibility of Endovascular Repair of Ascending Aortic Pathologies

Run by Baylor Research Institute · NCT03322033 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a new way to repair the ascending aorta in patients with type A aortic dissections to see if it helps improve their outcomes.

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment20 (estimated)
SponsorBaylor Research Institute
Academic / other
Locations1 site (Plano, Texas)
Trial IDNCT03322033 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with type A thoracic aortic dissection or retrograde type A dissection affecting the ascending thoracic aorta without aortic valve involvement.

Probably not a fit

Patients with aortic valve involvement or those not suitable for endovascular repair will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This early feasibility study aims to evaluate the outcomes of patients with ascending thoracic aortic pathologies, specifically type A aortic dissection, who are eligible for endovascular repair using the Medtronic Valiant PS-IDE Stent Graft System. The study will focus on patients with dissections affecting the aorta between the Sinus of Valsalva and the innominate artery orifice, ensuring no involvement of the aortic valve. The intervention involves repairing the ascending aorta by covering the proximal tear and rerouting blood to the true lumen. A total of 20 high-risk surgical patients will be enrolled in this study.

Why it matters

Potential benefit: If successful, this approach could provide a less invasive option for repairing life-threatening aortic dissections, potentially improving patient outcomes.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in endovascular techniques for aortic repair, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* In order to qualify for this physician-sponsored Investigational Device Exemption, the patients would have to meet the entire entry criteria listed below, sign a consent approved by the FDA and IRB, and agrees to follow-up according to the study protocol.

  * Patient must have a type A thoracic aortic dissection, retrograde type A thoracic aortic dissection of the ascending thoracic aorta affecting the area between the Sinus of Valsalva and the innominate artery orifice (with no involvement of the aortic valve) and be considered a candidate for endovascular repair;

    * The proximal and distal landing zones for placement of graft should be at least 1 cm.
    * The proximal landing zone will allow placement of the stent graft as to not inhibit valvular function, occlude a coronary ostium or proximal bypass graft; The aortic root may be dissected, but the proximal tear site must be at least 1cm from the STJ (and within the above listed size criteria).
    * Distal landing zone must allow for continued perfusion of critical cerebral vessels;
    * The aorta as measured adventitial wall to adventitial wall must be greater than 28 mm and no more than 44 mm maximum diameter at both the proximal and distal landing zone.
    * The patient must be high-risk surgical candidate according to the following established criteria: ASA score of IV.

Exclusion Criteria:

* Pregnant or pediatric patients (younger than 21 years of age);
* Patients who have a condition that threatens to infect the stent graft/aortic valve prosthesis;
* Patients with allergies to the stent graft material;
* Patients or their legally authorized representative (LAR) who do not sign the informed consent;
* Patients with expected survival less than one year due to a condition other than the ascending aortic

Where it's running

  • Baylor Scott & White The Heart Hospital
    Plano, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Castor and Cratos Branched Aortic Grafts Registry for Thoracic Aortic Pathologies

    This European registry collects real-world data to see how Castor and Cratos branched stent grafts perform in adults with thoracic aortic diseases.

    Recruiting at 4 sites Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd · Hamburg and 3 other locations · NCT07668687

  • Radiation-Exposure Reduction in Peripheral Procedures using Rampart IC System

    This study tests whether using the Rampart IC System during elective femoral-artery access peripheral procedures reduces radiation exposure for patients.

    Recruiting Baylor Research Institute · Plano, Texas · NCT07467720

  • Microbiome in esophageal and stomach leaks

    This project will test whether microbes in leaked fluid and nearby tissue from adults with esophageal or stomach leaks differ in ways that affect healing and complications.

    Recruiting Baylor Research Institute · Dallas, Texas · NCT07424469

  • IVUS-guided revascularization of leg arteries

    This trial will test whether using ultrasound inside the blood vessels during minimally invasive treatment of leg arteries improves outcomes for adults with symptomatic peripheral artery disease.

    Recruiting at 4 sites Baylor Research Institute · Dallas, Texas and 5 other locations · NCT07353905

  • Robotic exoskeletons for early walking after heart or chest surgery

    This will try using a wearable robotic exoskeleton to help adults who had heart or chest surgery get up and walk sooner compared with usual early ambulation.

    Recruiting Baylor Research Institute · Dallas, Texas · NCT07353892

  • Donor human milk cream to treat low blood sugar in newborns

    This pilot will see if a pasteurized donor human milk cream given to newborns at risk for low blood sugar can raise and help sustain their blood glucose.

    Recruiting Baylor Research Institute · McKinney, Texas · NCT07217483

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.